https://www.patsnap.com/resources/blog/rd-blog/fundus-cameras-and-handheld-retinal-imaging-patent-landscape/ · Patsnap · data cut-off 2026-07-31 · downloaded from the live page
Medical Imaging Patent Landscape
Fundus Camera and Handheld Retinal Imaging Patents
  • 27.7% of all 4,618 records sit with just five assignees, yet the ranked list runs 100 companies deep with a long tail of single-filer entrants.
  • Filings fell 61% from 318 in 2021 to 123 in 2024 (the last complete year) after peaking at 335 in 2018 — a field past its filing peak, not a growing one.
  • A61B carries 79.3% of records while G16H healthcare informatics sits at only 6.5%, pointing to where imaging-adjacent software claims remain thin.
Get a prior-art report on your approach
4,618
Published Records
28%
Top-5 Share of All Records
-61%
Filing Growth 2021→2024
US
Leading Jurisdiction

Filing growth compares 2021 (318 records) with 2024 (123) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 4,618 records in scope (CR5), not by the ranked leaders only.

Published byPatsnap Research··7 min readSourced from Patsnap Eureka
Field Overview

What the fundus camera and retinal imaging patent record shows

Fundus cameras and handheld retinal imaging devices sit at the intersection of optical hardware and diagnostic software: illumination geometry, pupil dilation workarounds, and field-of-view optics compete for claim space alongside image-quality processing. The scope here covers 4,618 published records filed between 2015 and mid-2026, drawn from search terms spanning device design (pupil dilation, field of view, illumination uniformity) and commercial constraints (device cost, operator training) that separate clinical-grade systems from consumer-facing screening tools.

Filing activity peaked in 2018 and has declined through the most recent complete year, 2024, though publication lag of roughly 18 months means the last one to two years in any chart will always understate true filing activity. The composition of IPC classes shows the field is still anchored in diagnostic hardware (A61B) rather than in the informatics layer built on top of it.

Filing activity by year, 2017-2026
  1. 1TOPCON CORPORATION443
  2. 2CANON KK374
  3. 3CARL ZEISS MEDITEC INC177
  4. 4CARL ZEISS MEDITEC AG143
  5. 5NIDEK CO LTD140
  6. 6BAYER PHARMA AG107
  7. 7NEUROVISION IMAGING LLC92
  8. 8NIKON CORP91
  9. 9APPLIED SPECTRAL IMAGING72
  10. 10KOWA CO LTD52
Source: Patsnap Eureka. Assignee ranking and totals. Derived from a Patsnap search on Fundus Cameras and Handheld Retinal Imaging covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Data Signals

Filing trends and technology composition

The two views below — filing volume over time and IPC subclass distribution — frame where activity has concentrated and where it has not.

A field past its 2018 peak

Filings rose to a peak of 335 in 2018, then declined; the 2021-to-2024 span alone shows a 61% drop, from 318 to 123 records. 2025 and 2026 figures are still filling in under normal publication lag and should not be read as confirmation of continued decline.

A field past its 2018 peak0100200300400159201733520182019202020212022202320242025312026Most recent year is partial — publication lag means later filings are not yet visible.

Diagnostic hardware still dominates

A61B (diagnosis and surgery) appears in 79.3% of the 4,618 records in scope, far ahead of G06T image processing (16.5%) and G16H healthcare informatics (6.5%). Because records often carry several IPC codes, these shares add to more than 100% — the gap between A61B and the informatics classes is the more useful signal than any single share.

Diagnostic hardware still dominatesA61B · Diagnosis & surgery3,66379.3%G06T · Image data processing & genera…76216.5%A61K · Medicinal preparations3287.1%G02B · Optical elements & systems3277.1%G16H · Healthcare informatics3016.5%A61P · Therapeutic activity of compou…2345.1%G06K · Data recognition & presentation2224.8%A61F · Implants & prostheses2004.3%Other1,86940.5%

Shares are the percentage of the 4,618 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.

Source: Patsnap Eureka. Filing trend and technology composition. Derived from a Patsnap search on Fundus Cameras and Handheld Retinal Imaging covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.

Go deeper on Fundus Cameras and Handheld Retinal Imaging with Eureka

This page is one run against one query. Ask Eureka your own question about fundus cameras and handheld retinal imaging and every answer comes back with the patent numbers behind it.

Try Eureka
Key Patents

Most-cited prior art and a representative filing

Representative Filing
US20070081127A12007-04-12

US20070081127A1 — Fundus camera for wide field of view and small pupil

CARESTREAM HEALTH, INC.

A fundus camera obtains a retinal image using a light source, a ring aperture conjugate to the cornea, and a first aperture conjugate to the iris. An apertured mirror redirects the ring illumination toward the eye. An objective lens between the apertured mirror and the eye has an entrance pupil positioned between the iris and the cornea, directing ring illumination into the pupil while passing the reflected retinal image back through the apertured mirror.Filed by Carestream Health, this 2007 filing shows the geometric approach — aperture conjugation and entrance pupil placement — that much later small-pupil fundus camera work has had to design around or license.

US20070081127A1 — patent drawing 1US20070081127A1 — patent drawing 2
View full record
Highest-cited records in scope
#Publication no.Patent titleCitations
1US5098426AMethod and apparatus for precision laser surgery1,211
2US5784162ASpectral bio-imaging methods for biological research, medical diagnostics and therapy786
3US20070291277A1Spectral domain optical coherence tomography system758
4US20080100612A1User interface for efficiently displaying relevant oct imaging data567
5US6556853B1Spectral bio-imaging of the eye490
6US6199986B1Rapid, automatic measurement of the eye's wave aberration470
7US6007996AIn situ method of analyzing cells464
8US6019472AContact lens element for examination or treatment of ocular tissues446
9US20100056928A1Digital light processing hyperspectral imaging apparatus444
10US6027216AEye fixation monitor and tracker439

Citation counts favour older filings in any searched corpus — treat them as a measure of influence on later filers, not of current commercial relevance.

Each row carries its publication number; clicking a row searches Eureka by that number.

Source: Patsnap Eureka. Citation counts and representative records. Derived from a Patsnap search on Fundus Cameras and Handheld Retinal Imaging covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Run it yourself

Put your own technology through the same analysis


  
Where to run it
Fastest

Eureka on the web

When you want the answer in the next five minutes.

The agent works the prompt against patents and technical literature, citing every source.

Run your analysis now →
For builders

MCP server & REST API

When it has to run inside your own pipeline.

Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.

Browse MCP servers →
Insights

Reading the concentration and citation data

Three figures from the dataset matter more than the raw filing count: how concentrated the leaderboard is, which receiving offices carry the volume, and which older records still anchor the citation graph.

Concentration
27.7%
of all 4,618 records held by top 5 assignees

A leader well ahead of a long tail

The top 5 assignees combined account for 27.7% of all records in scope, and the top 10 for 36.6%. Below that the ranking runs to 100 companies, with volume dropping fast — tenth place holds only 52 records against the leader's 443.

Concentration by record count, all 4,618 in scope
Filing office
1,951
US-filed records, the largest single office

US and EPO dominate the venue mix

The United States receives more filings than any other office (1,951), with Europe's EPO second (793) and the WIPO PCT route third (501). India's 203 records signal a growing secondary filing venue for cost-sensitive device variants.

Receiving office counts, absolute records
Citation anchor
1,211 citations
on the single most-cited record

Older spectral and laser-surgery art still anchors the field

The most-cited record in the set, US5098426A on precision laser surgery, carries 1,211 citations — well ahead of the next records on spectral bio-imaging and OCT. That gap shows how much of the field's foundational art predates the fundus-camera-specific filings now competing for claim space.

Citation counts within the searched corpus only
Eureka AI Agent
Looking for what nobody has claimed yet?

Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to fundus cameras and handheld retinal imaging, with the prior art for and against each one.

Find the white space →
Source: Patsnap Eureka. Co-assignee relationships and derived observations. Derived from a Patsnap search on Fundus Cameras and Handheld Retinal Imaging covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Players & Momentum

Who holds the ground, and where filing has stopped

The ranked leaderboard is dominated by established ophthalmic imaging manufacturers, but recent-year filing counts from those same assignees have gone flat or to zero — a signal that the core hardware claims may already be settled rather than that the field is dying.

Leader
443
records held by the top-ranked assignee

One company well ahead of the field

The top-ranked assignee holds 443 records against 140 for fifth place and 52 for tenth — a steep drop-off that marks this as a leader-plus-long-tail field rather than an evenly split one.

Based on the 100-company ranked list
Momentum
-88% to -100%
YoY change among the largest filers in the latest year

The largest historical filers have gone quiet

Recent-year filing counts from several of the top-ranked assignees have dropped to 0-2 records, with year-over-year changes as steep as -100%. That pattern is consistent across multiple leaders, not isolated to one company.

Latest-year counts against prior year, by assignee
Collaboration
10 pairs
co-assignee pairs identified

Collaboration is concentrated, not widespread

Only 10 co-assignee pairs appear in the dataset, and the strongest single pairing — between two Carl Zeiss Meditec entities — accounts for 80 shared records, far more than any academic-industry pairing in the set.

Pair counts across the full record set
🔍
Sub-areas still open for new claims
Filing density sits almost entirely in core optics and diagnostic hardware; these adjacent branches carry comparatively few records.
Illumination uniformity correction algorithmsSmall-pupil imaging without pharmacological dilationOperator-training-free autofocus for handheld unitsDevice-cost-optimised optical assembliesHealthcare informatics integration for retinal images
Rank all filers by momentum →
Recent-year filing momentum by assignee
AssigneeRecent yearYoY
Topcon Corporation2-88%
Canon Inc.0-100%
Carl Zeiss Meditec, Inc.0-100%
Carl Zeiss Meditec AG0-100%
Nidek Co., Ltd.0
Bayer Pharma AG0-100%
Nikon Corporation0-100%
APPLIED SPECTRAL IMAGING0
Source: Patsnap Eureka. Assignee-level momentum. Derived from a Patsnap search on Fundus Cameras and Handheld Retinal Imaging covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
What's Next

Where to take this analysis

The dataset points to a field with settled hardware claims at the top and thin coverage in the informatics layer around it. Two directions follow from that.

Map the informatics gap in detail

G16H healthcare informatics sits at just 6.5% of records against A61B's 79.3% — a gap worth mapping claim by claim before building a retinal-imaging software product on assumptions about open space.

Explore this gap in Eureka

Check design-around options against the leader's portfolio

With 443 records at the top of the ranking and steep concentration in the top 5, any new hardware filing should be checked against that portfolio's claim scope before development, not after.

Run a freedom-to-operate scan in Eureka
Source: Patsnap Eureka. Forward-looking reading of the same dataset. Derived from a Patsnap search on Fundus Cameras and Handheld Retinal Imaging covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
FAQ

Common questions about fundus camera patents

Answers are grounded in the same dataset. Derived from a Patsnap search on Fundus Cameras and Handheld Retinal Imaging covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Research Fundus Cameras and Handheld Retinal Imaging in depth with Eureka

Go past this page: query the whole fundus cameras and handheld retinal imaging corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.

Try Eureka

Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.

Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.

Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.